Abstract: A method (and system) for using information contained within the scanned image to create, in an automated (or semi-automated) process, an accurate data grid. The process has steps: enhance the image; locate blocks of spots; and find each individual spot in each of the blocks. Preferably, the method makes use of image filtering using a “Principal Frequency Filter” based on a mathematical determination of major periodic elements in the image to eliminate noisy, non-periodic signals, and of smoothed intensity profiles of the filtered image data. Here, the term Principal Frequency Filter is used to indicate an image-enhancing filter based upon a mathematical operation which identifies the major periodic components of the image.

Abstract: A method (and system) for using information contained within the scanned image to create, in an automated (or semi-automated) process, an accurate data grid. The process has steps: enhance the image; locate blocks of spots; and find each individual spot in each of the blocks. Preferably, the method makes use of image filtering using a “Principal Frequency Filter” based on a mathematical determination of major periodic elements in the image to eliminate noisy, non-periodic signals, and of smoothed intensity profiles of the filtered image data. Here, the term Principal Frequency Filter is used to indicate an image-enhancing filter based upon a mathematical operation which identifies the major periodic components of the image.

Abstract: Disclosed are peptides and peptide mimetics that bind selectins, including endothelial leukocyte adhesion molecule 1 (ELAM-1). Such peptides and peptide mimetics are useful in methods for blocking adhesion of leukocytes to the selectins for the purpose of inhibiting inflammation as well as in diagnostic methods employing labeled peptides and peptide mimetics that bind selectins for the purpose of determining the site of inflammation in mammals which inflammation is mediated by the presence of one or more selectins.

Abstract: Disclosed are peptides and peptide mimetics that bind selectins, including endothelial leukocyte adhesion molecule 1 (ELAM-1). Such peptides and peptide mimetics are useful in methods for blocking adhesion of leukocytes to the selectins for the purpose of inhibiting inflammation as well as in diagnostic methods employing labeled peptides and peptide mimetics that bind selectins for the purpose of determining the site of inflammation in mammals which inflammation is mediated by the presence of one or more selectins.

Abstract: The peptide HITWDQLWNVMN (SEQ ID NO: 4) and related peptides and peptidomimetics bind to endothelial leukocyte adhesion molecule 1 and block the binding of leukocytes to this important receptor and so can be used to ameliorate the detrimental effects of certain disease conditions.

Abstract: Disclosed are peptides and peptide mimetics that bind selectins, including endothelial leukocyte adhesion molecule 1 (ELAM-1). Such peptides and peptide mimetics are useful in methods for blocking adhesion of leukocytes to the selectins for the purpose of inhibiting inflammation as well as in diagnostic methods employing labeled peptides and peptide mimetics that bind selectins for the purpose of determining the site of inflammation in mammals which inflammation is mediated by the presence of one or more selectins.

Abstract: Plasmid vectors are provided that carry complementary DNA (cDNA) clones coding for polypeptides exhibiting mammalian IgE binding factor activity. One of these clones contains an open reading frame consisting of 556 codons. The cDNA is derived from messenger RNA isolated from a rat/mouse T-cell hybridoma line. The cDNA was cloned by incorporation into a pcD plasmid vector. The plasmid vector also contains DNA segments from the SV40 virus, permitting expression of the cDNA to form a polypeptide having IgE potentiating activity after transfection into a mammalian host cell, such as monkey Cos7 cells.

Abstract: Immunosuppressive peptides having glycosylation inhibiting factor activity are provided.